Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Budde

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Transplantation Proceedings|December 5, 2017
Immunologic Long-term Outcomes of Living-Related Kidney Transplantations Depending on the Donor-Recipient RelationshipD Khadzhynov, F Halleck, L Lehner, et al.
Transplantation Proceedings|September 2, 1998
Antibody therapy in steroid-resistant rejectionJ Waiser, K Budde, M Schreiber, et al.
Transplantation Proceedings|June 11, 2010
Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysisM Salvadori, E Bertoni, K Budde, et al.
Transplantation Proceedings|August 15, 2002
Successful steroid withdrawal at the end of the 1st year after renal transplantion in mycophenolate mofetil-treated patientsK Budde, G Hallebach, S Geissler, et al.
Transplantation Proceedings|August 15, 2002
Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long-term cyclosporine-treated patients: 4-year follow-upK Budde, S Geissler, G Hallebach, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 21, 1998
Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysisS Morgera, K Budde, D Lampe, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Treating type 2 diabetes in renal insufficiency: the role of pioglitazoneL Fritsche, K Budde, P Glander, et al.
Diabetes & Metabolism|July 4, 2017
Identification of urine metabolites associated with 5-year changes in biomarkers of glucose homoeostasisN Friedrich, T Skaaby, M Pietzner, et al.
Transplantation Proceedings|December 26, 2001
Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipientsG Einecke, I Mai, F Diekmann, et al.
Transplantation Proceedings|December 31, 2003
20-year experience with elderly donors in living renal transplantationM Giessing, T Slowinski, S Deger, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Transplantation Proceedings|December 5, 2017
Immunologic Long-term Outcomes of Living-Related Kidney Transplantations Depending on the Donor-Recipient RelationshipD Khadzhynov, F Halleck, L Lehner, et al.
Transplantation Proceedings|September 2, 1998
Antibody therapy in steroid-resistant rejectionJ Waiser, K Budde, M Schreiber, et al.
Transplantation Proceedings|June 11, 2010
Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysisM Salvadori, E Bertoni, K Budde, et al.
Transplantation Proceedings|August 15, 2002
Successful steroid withdrawal at the end of the 1st year after renal transplantion in mycophenolate mofetil-treated patientsK Budde, G Hallebach, S Geissler, et al.
Transplantation Proceedings|August 15, 2002
Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long-term cyclosporine-treated patients: 4-year follow-upK Budde, S Geissler, G Hallebach, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 21, 1998
Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysisS Morgera, K Budde, D Lampe, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Treating type 2 diabetes in renal insufficiency: the role of pioglitazoneL Fritsche, K Budde, P Glander, et al.
Diabetes & Metabolism|July 4, 2017
Identification of urine metabolites associated with 5-year changes in biomarkers of glucose homoeostasisN Friedrich, T Skaaby, M Pietzner, et al.
Transplantation Proceedings|December 26, 2001
Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipientsG Einecke, I Mai, F Diekmann, et al.
Transplantation Proceedings|December 31, 2003
20-year experience with elderly donors in living renal transplantationM Giessing, T Slowinski, S Deger, et al.
Pageof 16